TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Construction in Progress (2020 - 2025)

Updated

TScan Therapeutics' Construction in Progress was $118,000 in Q4 2025, up 18.0% from $100,000 a year earlier.

Analysis

TScan Therapeutics (TCRX) Construction in Progress (2020 - 2025) Analysis & Trends

From Q4 2020 onward, TScan Therapeutics has reported Construction in Progress for 6 quarters.

  • Construction in Progress shows a five-year compound annual growth rate of -31.4% (FY2020 to FY2025).
  • In earlier years, Construction in Progress was $100,000 in FY2024 (-81.8%), $548,000 in FY2023, $5,000 in FY2022 (-99.6%) and $1.26 million in FY2021 (+62.3%).
  • The Q4 2025 figure marks the highest quarterly Construction in Progress since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 118,000.00
Dec 31, 2024 100,000.00
Dec 31, 2023 548,000.00
Dec 31, 2022 5,000.00
Dec 31, 2021 1.26 Mn
Dec 31, 2020 778,000.00
API Access

TScan Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=TCRX&period=max&api_key=YOUR_API_KEY